Evidence map›Paper›PMID 40218778›Full record

ArticleSensors (Basel, Switzerland)2025

Membrane Permeability Monitoring to Antipsychotic Olanzapine Using Platinum Black-Modified Electrodes.

Murugaiya Sridar Ilango, Dayananda Desagani, Srikanth Jagadeesan, Alexander Snezhko, Gad Vatine, Hadar Ben-Yoav

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Murugaiya Sridar IlangoNanobioelectronics Laboratory, Department of Biomedical Engineering, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.ORCID 0000-0002-1915-2739
Dayananda DesaganiNanobioelectronics Laboratory, Department of Biomedical Engineering, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.
Srikanth JagadeesanDepartment of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.
Alexander SnezhkoNanobioelectronics Laboratory, Department of Biomedical Engineering, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.
Gad VatineDepartment of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.ORCID 0000-0003-3674-1671
Hadar Ben-YoavNanobioelectronics Laboratory, Department of Biomedical Engineering, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.ORCID 0000-0002-6237-0440

Funding

Israel Science Foundation 1052/19
6 · The paper itself

Abstract

The blood-brain barrier (BBB) is key to the regular functioning of the central nervous system. The dysfunction of the BBB has been described in various neurological disorders, including schizophrenia. Schizophrenia (SCZ) is a chronic psychiatric disorder described by hallucinations, delusions, and negative symptoms. The Olanzapine (OLZ) drug is an electroactive species, and its levels can be monitored using electrochemical sensors. The detection of OLZ was demonstrated previously by using electrochemical sensors, and this technique can be used to monitor the levels of OLZ in real time. The challenge is to identify the permeability of OLZ through the BBB, so a replica model was designed with the BBB based on a Transwell membrane seeded with endothelial cells. A microfabricated electrode consisting of a 3 mm Au disk was modified with platinum black; this enables higher selectivity of electrochemical signals from OLZ. The dose-response of OLZ was characterized in phosphate buffer saline solution (10 mM, pH 7.4) by adding 20-200 nM (in steps 20) of OLZ stock solution. The observed chronoamperometric electrochemical signals showed an increasing current at 0.45 V vs. Ag/AgCl with an increasing OLZ concentration. The controls for the experiments were performed in phosphate-buffered saline solution (10 mM, pH 7.4). The detection limit was calculated as 9.96 ± 7.35 × 10

Indexed as

Antipsychotic AgentsCell Membrane PermeabilityOlanzapinePlatinumBiosensing TechniquesBlood-Brain BarrierElectrochemical TechniquesElectrodesEndothelial CellsHumansPermeabilitySchizophreniaAntipsychotic AgentsOlanzapinePlatinumblood–brain barrierelectrochemical sensorsolanzapineplatinum blackschizophrenia

Identifiers

PMID40218778
PMCPMC11991649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.